Clinical Trial Update: A Phase 1, Single-Ascending-Dose, Safety, Tolerability, Pharmacokinetic(PK), and Pharmacodynamic(PD) Study of BIIB068 in Healthy Participants [Phase 1]

View source ↗

Summary

This clinical trial update describes the completion of a Phase 1 single-ascending-dose study of BIIB068 in healthy participants, assessing safety, tolerability,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BIIB068

Snippet

Sponsor: Biogen | Conditions: Systemic Lupos Erythematosus, SLE | Phase 1 | Status: COMPLETED